Frontlight ResearchEarly access
Active, not recruitingNo phase
Genomics of Sudden Cardiac Arrest
Key facts
- Who runs it
- University of Washington
- Where
- Seattle, United StatesSee the site
- Trial code
- Status
- Active, not recruiting
- People taking part
- 14,862 people enrolled
- Started
- Sept 2007
- Expected to end
- Aug 2030
- Type of study
- Observational, 4 groups
- Record updated
- 5 June 2023
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- Experienced incident SCA
- Matched to people with SCA on age, gender, and ethnicity
Who cannot take part
- Members of a vulnerable population
Where in United States
- Cardiovascular Health Research Unit, University of WashingtonSeattle, United States
About the trial
What the trial wants to find out
Sudden cardiac arrest (SCA) is a sudden, unexpected loss of heart function. It is a leading cause of death, and more than 400,000 people in the United States die each year as a result of SCA. This study will analyze genetic samples of people who have experienced SCA and people who have not experienced SCA to determine if there is a genetic basis for SCA.
The 4 groups in the trial
- 1
European American people who have experienced SCA.
- 2
European American people who have not experienced SCA.
- 3
African American people who have experienced SCA.
- 4
African American people who have not experienced SCA.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Evaluating the Genetic Factors That May Lead to Sudden Cardiac Arrest (The GenSCA Study)
- Record updated
- 5 June 2023